EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease

Jennifer Petrillo iD, Ruta Sawant, Rebecca Rogers iD, Sophie Cleanthous, Stefan Cano iD, Rajeev Kumar, Jennifer Klapper iD, Luis A Sierra iD, Jee Bang, Karen Elta Anderson iD, Deborah A Hall, Susan Perlman und 4 weitere

Journal of Huntington's Disease · 2025-11 · 14 (4) · 369-381

DOI: 10.1177/18796397251358375 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Huntington's Disease, online erschienen am 22.07.2025. Verfasst von Jennifer Petrillo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Sage Therapeutics, Inc., Cambridge, MA, USA. Hauptthemen laut MEDLINE: Huntington Disease, Activities of Daily Living, Patient Reported Outcome Measures, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sage Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Huntington's Disease (HD) Everyday Functioning (Hi-DEF) is a novel patient-reported outcome (PRO) scale developed to assess the impact of cognitive impairment on daily functioning in early HD patients.

Objective

To examine the psychometric properties, including reliability and validity, of the Hi-DEF. Findings from psychometric analyses using classical test theory (CTT) approach are presented here.

Methods

A non-interventional validation study was conducted across nine HD Centers of Excellence across the US.

Results

Patients with HD (n = 151) were recruited: 59% were female, mean (SD) age was 47 (12) years, and mean (range) Total Functional Capacity (TFC) score was 11.4 (8–13). Excellent internal consistency reliability was observed for the Hi-DEF scale total score (Cronbach's alpha: 0.98) and across subscales (alpha range 0.87–0.96). Most targeting and scaling assumptions were met, although there were ceiling effects for three subscales. Construct validity was demonstrated by moderate to high Spearman's rank-order correlations with TFC scores (range r = −0.38 to −0.62) and known and validated measures such as the HD-PRO-TRIAD TM (range r = 0.75–0.90), and ability to discriminate between levels of functional impairment (TFC 13, 12–11, and 10–8; p < 0.001). Correlations with Cambridge Neuropsychological Test Automated Battery (CANTAB) cognitive performance measures were low to moderate and ranged from 0.06 to 0.38.

Conclusions

The Hi-DEF is a reliable and valid PRO scale measuring the impact of cognitive impairment on daily functioning, assessing facets of cognitive functioning in context of activities of daily living impacted in early stages of HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseActivities of Daily LivingPatient Reported Outcome MeasuresCognitive DysfunctionHumansFemaleMiddle AgedMaleReproducibility of ResultsAdultPsychometricsNeuropsychological TestsAged

Stichwörter der Autor:innen

Huntington's diseaseactivities of daily livingexecutive functionpsychometricsreliabilityvalidity

Autor:innen und Institutionen

  • Sage Therapeutics, Inc., Cambridge, MA, USA.
  • Modus Outcomes, a Division of THREAD, Cambridge, MA, USA.
  • Rocky Mountain Movement Disorders, Englewood, CO, USA.
  • University of Pennsylvania Huntington's Disease Center, Philadelphia, PA, USA.
  • Beth Israel Deaconess Medical Center, Clinical Research Trials Excellence in Neurology (CORTEX), Boston, MA, USA.
  • Johns Hopkins Medicine, Neurology, Baltimore, MD, USA.

ORCID-Profile: Jennifer Petrillo, Rebecca Rogers, Stefan Cano, Jennifer Klapper, Luis A Sierra, Karen Elta Anderson, Henry Moore, Jason Johannesen, Emma Elliott

Förderung

  • Sage Therapeutics

Zitieren

APA

Petrillo, J., Sawant, R., Rogers, R., Cleanthous, S., Cano, S., Kumar, R., Klapper, J., Sierra, L. A., Bang, J., Anderson, K. E., Hall, D. A., Perlman, S., Moore, H., Bega, D., Johannesen, J., & Elliott, E. (2025). Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease. Journal of Huntington's Disease, 14(4), 369-381. https://doi.org/10.1177/18796397251358375

Vancouver

Petrillo J, Sawant R, Rogers R, Cleanthous S, Cano S, Kumar R, et al. Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease. Journal of Huntington's Disease. 2025;14(4):369-381. doi:10.1177/18796397251358375

BibTeX
@article{Petrillo2025,
  author = {Petrillo, Jennifer and Sawant, Ruta and Rogers, Rebecca and Cleanthous, Sophie and Cano, Stefan and Kumar, Rajeev and Klapper, Jennifer and Sierra, Luis A and Bang, Jee and Anderson, Karen Elta and Hall, Deborah A and Perlman, Susan and Moore, Henry and Bega, Danny and Johannesen, Jason and Elliott, Emma},
  title = {Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease},
  journal = {Journal of Huntington's Disease},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {369--381},
  doi = {10.1177/18796397251358375}
}
Kostenlos starten →